ALK-Rearranged Non-Small Cell Lung Cancer is Associated with a High Rate of Venous Thromboembolism

被引：0

作者：

Zer, Alona ^{[1
]}

Moskovitz, Mor ^{[2
]}

Hwang, David ^{[3
]}

Hershko-Klement, Anat ^{[4
]}

Fridel, Ludmila ^{[1
]}

Korpanty, Grzegorz ^{[3
]}

Dudnik, Elizabeth ^{[1
]}

Peled, Nir ^{[1
]}

Shochat, Tzippy ^{[1
]}

Leighl, Natasha ^{[5
]}

Liu, Geoffrey ^{[6
]}

Feld, Ronald ^{[6
]}

Burkes, Ronald ^{[4
]}

Wollner, Mira ^{[2
]}

Tsao, Ming ^{[7
,8
]}

Shepherd, Frances ^{[6
]}

机构：

[1] Rabin Med Ctr, Petah Tiqwa, Israel

[2] Rambam Med Ctr, Haifa, Israel

[3] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[4] Mt Sinai Hosp, Toronto, ON, Canada

[5] Princess Margaret Canc Ctr, Med Oncol, Toronto, ON, Canada

[6] Princess Margaret Canc Ctr, Toronto, ON, Canada

[7] Princess Margaret Canc Ctr, Dept Pathol, Toronto, ON, Canada

[8] Univ Toronto, Toronto, ON, Canada

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

supportive care; side effects; survivorship; lung cancer;

D O I：

10.1016/j.jtho.2016.11.350

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

0A21.02

引用

页码：S326 / S327

页数：2

共 50 条

[21] Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer
Ando, Chihiro
Ichihara, Eiki
Nishi, Tatsuya
Morita, Ayako
Hara, Naofumi
Takada, Kenji
Nakasuka, Takamasa
Watanabe, Hiromi
Kano, Hirohisa
Nishii, Kazuya
Makimoto, Go
Kondo, Takumi
Ninomiya, Kiichiro
Fujii, Masanori
Kubo, Toshio
Ohashi, Kadoaki
Matsuoka, Ken-ichi
Hotta, Katsuyuki
Tabata, Masahiro
Maeda, Yoshinobu
Kiura, Katsuyuki
CANCER SCIENCE, 2023, 114 (11) : 4343 - 4354
[22] Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: Recent Progress and Future Directions
Laird Cameron
Benjamin Solomon
Drugs, 2015, 75 : 1059 - 1070
[23] Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non-Small Cell Lung Cancer
Mendoza, Dexter P.
Lin, Jessica J.
Rooney, Marguerite M.
Chen, Tianqi
Sequist, Lecia V.
Shaw, Alice T.
Digumarthy, Subba R.
AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (04) : 766 - 774
[24] New Strategies for Treatment of ALK-Rearranged Non-Small Cell Lung Cancers
Sasaki, Takaaki
Jaenne, Pasi A.
CLINICAL CANCER RESEARCH, 2011, 17 (23) : 7213 - 7218
[25] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
Kate McKeage
Drugs, 2015, 75 : 75 - 82
[26] Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
McKeage, Kate
DRUGS, 2015, 75 (01) : 75 - 82
[27] Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: Recent Progress and Future Directions
Cameron, Laird
Solomon, Benjamin
DRUGS, 2015, 75 (10) : 1059 - 1070
[28] Cardiac Toxicity of Crizotinib Therapy in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
Zhang, Yan
Wang, Yan
Li, Junling
Hao, Xuezhi
Ma, Di
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S377 - S377
[29] Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
Sankar, Kamya
Nagrath, Sunitha
Ramnath, Nithya
CANCERS, 2021, 13 (06)
[30] Targeting ALK-rearranged non-small-cell lung cancer: an update
Sullivan, Ivana
Planchard, David
FUTURE ONCOLOGY, 2017, 13 (14) : 1213 - 1217

← 1 2 3 4 5 →